Dogwood Therapeutics DWTX Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Common Shares Issued
Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Common Shares Issued at other companies
Other financials
Where this comes from
Reported directly by Dogwood Therapeutics in its filing.
Tagged under the XBRL concept dwtx:NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationCommonSharesIssued.
The official record: Dogwood Therapeutics’s 10-K, filed March 18, 2026, on SEC EDGAR. View the filing →
Ask your AI about Dogwood Therapeutics's noncash or part noncash acquisition noncash financial or equity instrument consideration common shares issued.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Dogwood Therapeutics's noncash or part noncash acquisition noncash financial or equity instrument consideration common shares issued?
- Dogwood Therapeutics (DWTX) reported noncash or part noncash acquisition noncash financial or equity instrument consideration common shares issued of $223.27K in Q4 2024.
- What does noncash or part noncash acquisition noncash financial or equity instrument consideration common shares issued mean?
- Captures the value of common shares issued as non-cash consideration for the acquisition of assets, businesses, or intellectual property. This metric reflects the use of equity as a strategic tool for expansion and asset procurement. It provides transparency into the dilution effects associated with non-cash corporate development activities.